secwatch.observer — SEC 8-K summary
======================================

Issuer:     Acutus Medical, Inc. (—)
CIK:        0001522860
Form:       8-K
Filed at:   2024-01-11T23:59:59+00:00
Accession:  0001628280-24-001153
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acutus Medical appoints Takeo Mukai as CEO; David Roman becomes consultant
--------------------------------------------------------------------------

- David Roman departed as president and CEO effective Jan 7, 2024; also resigned from board.
- Takeo Mukai, formerly CFO, appointed CEO effective Jan 8, 2024, retaining CFO role.
- Mukai's base salary increased from $325,000 to $375,000; target bonus raised to 60% of base.
- Roman entered consulting agreement at $200/hour through Dec 31, 2024 to assist with transition and strategic options.
- Board size set at seven members.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1522860/000162828024001153/0001628280-24-001153-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1522860/000162828024001153/afib-20240107.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-001153

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer